A5025381085- Acute Ischemic Stroke Management
- Long-Term Effects of COVID-19
- Stroke Rehabilitation and Recovery
- COVID-19 Clinical Research Studies
- COVID-19 and healthcare impacts
- Cerebrovascular and Carotid Artery Diseases
- Pharmaceutical industry and healthcare
- Retinal and Optic Conditions
- Venous Thromboembolism Diagnosis and Management
- Infectious Encephalopathies and Encephalitis
- Neurological Disorders and Treatments
- Pharmaceutical Economics and Policy
- Intracranial Aneurysms: Treatment and Complications
- Health Systems, Economic Evaluations, Quality of Life
- COVID-19 and Mental Health
- Traumatic Brain Injury and Neurovascular Disturbances
- Intracerebral and Subarachnoid Hemorrhage Research
- Epilepsy research and treatment
- SARS-CoV-2 and COVID-19 Research
- Peripheral Neuropathies and Disorders
- Autoimmune Neurological Disorders and Treatments
- Healthcare cost, quality, practices
- Climate Change and Health Impacts
- COVID-19 diagnosis using AI
- Myasthenia Gravis and Thymoma
University of Arkansas for Medical Sciences
2018-2025
University of Arkansas Medical Center
2025
University of Applied Management Studies
2020-2023
University of Arkansas at Little Rock
2018-2023
Boston Medical Center
2021-2022
Boston University
2021-2022
Hospital de Egas Moniz
2022
University of Thessaly
2022
Hospital de Clínicas de Porto Alegre
2021
Ochsner Medical Center
2020-2021
All authors have no conflicts of interest to disclose.
To study the risk of acquiring Corona Virus Disease 2019 (COVID-19) and its outcomes in patients on immunosuppressive therapy (IST) for chronic autoimmune neuromuscular disorders (aNMD) multiple sclerosis (MS).
Acute encephalopathy with COVID-19 has been reported in several studies but its impact on outcomes remains unclear. We hypothesized that hospitalized patients have worse related outcomes.
In this study, we aim to identify predictors of a no-show in neurology clinics at our institution. We conducted retrospective review from July 2013 through September 2018. compared odds ratio patients who missed appointments (no-show) those were present (show) terms age, lead-time, subspecialty, race, gender, quarter the year, insurance type, and distance hospital. There 60,012 (84%) show 11,166 (16%) patients. With each day increase lead time, increased by factor 1.0019 (p < 0.0001). Odds...
Background: Limited data exist on the safety of combining antiplatelets and anticoagulants (AC) for secondary stroke prevention in acute ischemic (AIS). We sought to examine hemorrhage risk with single (SAPT) or dual antiplatelet therapy (DAPT) AC AIS patients concomitant atrial fibrillation (AF) myocardial infarction (MI). Methods: This retrospective cross-sectional cohort study used TriNetX, a federated health analytics database that collects real-time electronic records from 76...
Background: The University of Arkansas for Medical Sciences (UAMS) Institute Digital Health&Innovation (IDHI) – Telestroke Program provides neurology support to 62 spoke hospitals across Arkansas. We retrospectively reviewed stroke consults who received Alteplase or Tenecteplase during the 2023 calendar year, determine if years program training influences time metrics. examined Door CT (Door2CT) and Lytic (Door2Lytic) with hospital size year joined telestroke program. Methods: Sixty-two...
As effective vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerge, it is important to have timely real-word data that guides immunization prioritization for our patients and especially possibly more vulnerable neuromuscular populations [1COVID-19 Vaccines. 2021https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/covid-19-vaccinesGoogle Scholar]. Recent shown with chronic autoimmune disorders who are on immunosuppression...
The clinical presentation of contrast-induced encephalopathy (CIE) varies widely, including altered mental status, focal motor and sensory deficit, visual disturbance, ophthalmoplegia, global aphasia, seizures.
A 24-year-old man with no relevant medical history presented to our institution a week of intermittent dizziness exacerbated by turning his head the left. He acutely developed diplopia and disorientation on day presentation emergency room. reported similar complaints month prior. There was fevers, rashes, headache, or neck trauma. family complaints, vascular connective tissue diseases, stroke-like episodes, seizures, early-onset dementia. Examination demonstrated mild impairment cognition...
Background and Purpose- Industry payments to physicians raise concerns regarding conflicts of interest that could impact patient care. We explored nonresearch nonownership from industry vascular neurologists identify trends in compensation. Methods- Using Centers for Medicare Medicaid Services American Board Psychiatry Neurology data, we financial relationships between US 2013 2018. analyzed payment characteristics, including categories, distribution among physicians, regional trends,...
Objective To explore effectiveness of alternative methods neurology resident electroencephalogram (EEG) learning during COVID-19 pandemic due to social distancing requirements which caused disruption traditional in-person teaching. Methods Virtual EEG was instituted using Zoom platform. Residents participated in live, interactive virtual sessions for eight weeks. A pre-test and post-test were administered a survey performed at the end project. Results Based on results, there significant...
Corona Virus Disease 2019 (COVID-19) cases continue to increase around the World. Typical symptoms include fever and respiratory illness but a constellation of multisystem involvement including central nervous system (CNS) peripheral (PNS) have been reported with COVID-19. Acute ischemic strokes (AIS) also as complication.We analyzed patient characteristics, clinical outcomes, laboratory results imaging four patients COVID-19 who had AIS.All were =< 60 years, hypoxemic failure secondary...
It is uncertain if patients with prior ischemic stroke are vulnerable to coronavirus disease 2019 (COVID-19) and its complications.We used TriNetX, a global health collaborative clinical research platform large COVID-19 database. infection was identified positive lab value for severe acute respiratory syndrome 2 (SARS-CoV-2) related ribonucleic acid (RNA).A total of 604,258 history were identified, which 891 (study cohort) diagnosed COVID-19. A control cohort 32,136 after January 20th 2020...
Background Studying critical time interval requirements can enhance thrombolytic treatment for stroke patients in telestroke networks. We retrospectively examined 12 concurrent months of targeted information the South Central US telemedicine programme, Arkansas Stroke Assistance through Virtual Emergency Support (AR SAVES). Hypothesis: hypothesised that consult data analysis would highlight areas improvement to shorten overall door Intra venous (IV) tissue plasminogen activator (tPA)...
Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) is an ongoing pandemic that has affected over 400 million people worldwide and caused nearly 6 deaths. Hemorrhagic encephalitis uncommon but serious complication of COVID-19. The etiology this disease multifactorial, including secondary to severe hypoxemia, systemic inflammation, direct viral invasion, hypercoagulability, etc. clinical spectrum COVID-19-related hemorrhagic also varied, ranging from leukoencephalopathy with...
Abstract Objective: The World Health Organization declared monkeypox (MPX), a global health crisis, in July 2022. Its symptoms include fever, rash, lymphadenopathy, myalgias, and fatigue; there have also been the reports of neurological manifestations no data on psychiatric manifestations. In our study, we aimed to study neurologic MPX patients. Methodology: Our used TriNetX database identify patients along with their age, gender, race, ethnicity, geographic location data. Using...
The purpose of this study was to determine reasons for not giving intravenous tissue plasminogen activator eligible patients with acute ischemic stroke in a telestroke network.We performed retrospective analysis prospectively collected data who were seen as consultation during 2015 and 2016 the Arkansas Stroke Assistance through Virtual Emergency Support programme possible stroke.Total consultations 809 744 2016, out which 238 247 received activator. In remaining 571 497 patients, 294 200...